Apoptosis
Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
- Caspase(102)
- 14.3.3 Proteins(2)
- Apoptosis Inducers(45)
- Bax(7)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(67)
- MDM2(15)
- p53(128)
- PC-PLC(5)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(151)
- Other Apoptosis(900)
- Apoptosis Detection
- Caspase Substrate
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(32)
Apoptosis 相关产品(2721)
- GC16409Oligomycin BCAS: 11050-94-5纯度: >85.00%
A nonselective inhibitor of the mitochondrial F 1 F O ATP synthase
- GC16497SGI-1776 free baseCAS: 1025065-69-3纯度: >99.00%
SGI-1776 free base是一种ATP竞争性的Pim激酶抑制剂,可抑制Pim-1(IC 50 =7nM)、Pim-2(IC 50 =363nM)和Pim-3(IC 50 =69nM)的活性。
- GC16516BCH (LAT1-IN-1)CAS: 20448-79-7纯度: >99.00% / >98.00% / >97.00% / >95.00%
BCH (LAT1-IN-1)是一种具有选择性和竞争性的L型氨基酸转运蛋白1(LAT1)抑制剂。
- GC16673N-Formyl-Met-Leu-PheCAS: 59880-97-6纯度: >99.50%
N-Formyl-Met-Leu-Phe是一种内源性趋化肽,也是甲酰肽受体1(FPR1)的激动剂,Ki值为38 nM。
- GC16732TSU-68 (SU6668,Orantinib)CAS: 252916-29-3纯度: >98.50%
An inhibitor of select receptor tyrosine kinases
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC16389 | BAY 61-3606 | 732983-37-8 | - | |
A Syk inhibitor | ||||
| GC16409 | Oligomycin B | 11050-94-5 | >85.00% | |
A nonselective inhibitor of the mitochondrial F 1 F O ATP synthase | ||||
| GC16436 | Tenovin-6 | 1011557-82-6 | >98.50% | |
A small molecule activator of p53 | ||||
| GC16450 | Prednisone | 53-03-2 | >99.50% / >98.00% | |
A synthetic glucocorticoid | ||||
| GC16479 | UC 112 | 383392-66-3 | >99.50% | |
UC 112 是一种新型强效 IAP(凋亡抑制剂)抑制剂;有效抑制两种人黑色素瘤(A375 和 M14)和两种人前列腺(PC-3 和 DU145)癌细胞系的细胞生长(IC50\u003d0.7-3.4 uM)。 | ||||
| GC16497 | SGI-1776 free base | 1025065-69-3 | >99.00% | |
SGI-1776 free base是一种ATP竞争性的Pim激酶抑制剂,可抑制Pim-1(IC 50 =7nM)、Pim-2(IC 50 =363nM)和Pim-3(IC 50 =69nM)的活性。 | ||||
| GC16499 | Sorafenib Tosylate | 475207-59-1 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC16511 | OTS964 | 1338545-07-5 | >99.00% | |
A TOPK inhibitor | ||||
| GC16516 | BCH (LAT1-IN-1) | 20448-79-7 | >99.00% / >98.00% / >97.00% / >95.00% | |
BCH (LAT1-IN-1)是一种具有选择性和竞争性的L型氨基酸转运蛋白1(LAT1)抑制剂。 | ||||
| GC16517 | Eugenol | 97-53-0 | >98.00% | |
丁香酚是一种存在于丁香中的精油,具有抗菌、驱虫和抗氧化活性。 | ||||
| GC16519 | ENMD-2076 | 934353-76-1 | >98.00% | |
A multi-kinase inhibitor | ||||
| GC16589 | Limonin | 1180-71-8 | >99.50% | |
柠檬苦素是一种天然的四环三萜类化合物,广泛存在于桉树、黄柏和黄连中。 | ||||
| GC16597 | Alda 1 | 349438-38-6 | >99.50% | |
Alda 1是一种醛脱氢酶2(ALDH2)激活剂。 | ||||
| GC16625 | CDDO-TFEA | 932730-52-4 | >99.50% | |
A synthetic triterpenoid with potent anticancer and neuroprotective activity | ||||
| GC16661 | Citrinin | 518-75-2 | >98.00% | |
Citrinin是一种具有多种生物活性的霉菌毒素,由青霉属、曲霉属和红曲霉属的几种真菌菌株产生。 | ||||
| GC16673 | N-Formyl-Met-Leu-Phe | 59880-97-6 | >99.50% | |
N-Formyl-Met-Leu-Phe是一种内源性趋化肽,也是甲酰肽受体1(FPR1)的激动剂,Ki值为38 nM。 | ||||
| GC16684 | Docetaxel | 114977-28-5 | >99.50% | |
Docetaxel是紫杉烷类抗有丝分裂化疗药物,IC50为0.2 µM。 | ||||
| GC16694 | TAE684 (NVP-TAE684) | 761439-42-3 | >99.00% | |
A selective ALK inhibitor | ||||
| GC16701 | SKI II | 312636-16-1 | >99.50% / >98.00% | |
An SPHK1 inhibitor | ||||
| GC16711 | PNU 74654 | 113906-27-7 | >99.00% | |
An inhibitor of β-catenin/Wnt signaling | ||||
| GC16713 | HS-173 | 1276110-06-5 | >98.00% | |
A PI3K inhibitor | ||||
| GC16732 | TSU-68 (SU6668,Orantinib) | 252916-29-3 | >98.50% | |
An inhibitor of select receptor tyrosine kinases | ||||
| GC16733 | Vildagliptin (LAF-237) | 274901-16-5 | >98.00% | |
A DPP-4 inhibitor | ||||
| GC16734 | Pracinostat (SB939) | 929016-96-6 | >99.50% | |
A pan-HDAC inhibitor | ||||
